Dr Nicholas Syn graduated from the National University of Singapore, where he currently serves as Adjunct Assistant Professor in the School of Medicine. During medical school, Dr Syn obtained several grants and awards, and upon graduation became the first recipient of the Dean's Research and Development Award (DRDA). He also attained institutional awards including the Abbott Academic Excellence Prize, Yeoh Seang Aun Prize (in Tuberculosis and Infectious Diseases), SingHealth Medical Student Talent Development Awards (twice), NUHS Department of Medicine Junior Research Award, Wong Hock Boon Society Research Fellowship Grant, NUS Medical Grand ChallengeChange Maker Prize, and NUS Enterprise Innovation And Entrepreneurship Practicum Grant.
Professionally, he currently serves as a member of the Vanguard Committee of the International Liver Transplantation Society, and as an associate editor for several journals in the BMC and Frontiers portfolio. He Co-Founded and serves as the Chief Scientific Officer of LiverGenix Ptd Ltd, an NUS spin-off focused on data-driven precision medicine for liver diseases.
He is an active clinician-researcher and has published over 400 scientific manuscripts, including articles in top journals like The Lancet, The Lancet Oncology, Nature Communications, BMC Medicine, Journal of Clinical Oncology, BMJ Gut etc, and has presented at numerous prestigious conferences internationally. He was named among the World’s Top 2% of Scientists ranking published by Stanford University and Elsevier for three consecutive years based on calendar year citations in 2022, 2023 and 2024. He is also the principal investigator or collaborator on several national and institutional grants.
Dr Syn joined HMI OneCare in 2025 as Clinical Research Lead, focusing on private-public collaboration to enhance primary care and community health through data-driven research.
Find a clinic